S
SciClone is a US-based, China-focused specialty pharmaceutical company with a substantial revenue-generating and profitable commercial business and a broad, marketed product portfolio of differentiated therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders.
Investor insights
Funding rounds participated in
$134M sweet spot round size
Investor type
Public Company
Basic info
Industry
Pharmaceutical Manufacturing
Sectors
Pharmaceutical Manufacturing
Funding rounds raised
Total raised
$134M
from investors over 1 rounds
S
SciClone Pharmaceuticals raised $134M on March 19, 2021